PerkinElmer to Acquire Euroscreen Products in Bid to Fatten GPCR Play | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer today said it plans to acquire privately held GPCR company Euroscreen Products for an undisclosed amount.
Euroscreen Products provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
PerkinElmer CEO Gregory Summe said the acquisition is the company’s “next step in our strategy to build the most comprehensive offering in cellular and drug discovery reagent technologies.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.